Skip to main content
Caplight Logo









Seek Labs

Seek Labs

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://seeklabs.com/

Last Round

Grant

Feb 17, 2026

Total Funding Raised

$15.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Seek Labs is a biotechnology company that develops next-generation molecular diagnostic systems and programmable CRISPR-based therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

molecular diagnosticsCRISPR therapeuticsAI discovery enginepoint-of-care diagnosticsinstrument-free diagnosticsdecentralized diagnosticsportable molecular testingdrug discovery AIanimal healthpandemic readinessbiosecurityveterinary diagnosticsmedical countermeasuressynthetic biologytechnology licensinggenetic target identification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seek Labs Comparables

Compare Seek Labs with similar companies based on industry and business-model similarity.

Seek Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alveo Technologies
79%
Domus Diagnostics
77%
CrisprBits
77%

Seek Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2026
Series BAug 18, 2023

Key People

Founding team and executive leadership

Brad Bauer

Chief Technology Officer

Executive Team

Seek Labs Investors

Notable investors and investment history

Seek Labs investors
InvestorRounds
Weobly One CapitalSeries B
HomeStake Venture PartnersSeries B
U.S. Department of AgricultureGrant
UVB CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 79% MoM, reaching 2.7K.

  • Feb 17, 2026

    Secured $2M from the U.S. Department of Agriculture.

Seek Labs Filings

Explore SEC and related filing metadata, where available.

Seek Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Seek Labs's valuation, stock price, and market status.

Is Seek Labs a public or private company?

Seek Labs is a private company.

What is the current stock price of Seek Labs?

Seek Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Seek Labs worth (valuation)?

Valuation information for Seek Labs is not publicly available.

Can I buy Seek Labs stock?

Seek Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Seek Labs's last funding round?

Seek Labs's most recent funding round was Series B on August 18, 2023.

Who are the main investors in Seek Labs?

Key investors in Seek Labs include Weobly One Capital, HomeStake Venture Partners, UVB Capital.

Will Seek Labs IPO soon?

No public IPO plans have been announced for Seek Labs.

How can I track Seek Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seek Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range20
Year Founded2016
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?